.eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention. . . august 2015 (25) . . . . $17 OFF DEAL Birthday Collections From $17 @ Cosmetics Promo Codes 100% Success share 218 Used Today 50% OFF DEAL Up to 50% Off Velvet Lip Kits 100% Success share 181 Used Today $20 OFF DEAL $20 off all orders Brushes From $20 @ Cosmetics Promo Codes 100% Success share 200 Used Today